logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 인천지방법원 2020.01.17 2019고단8000
약사법위반
Text

Defendant

A shall be punished by a fine of 1,00,000 won and by imprisonment of 8 months for each of the defendants B.

Defendant

A The above fine shall be imposed.

Reasons

Punishment of the crime

Defendant

A is a person working as the office of “D” that sells lectures and beauty art materials related to beauty art in the second floor of the Gangnam-gu Seoul Metropolitan Government, and Defendant B is a representative of “E” that sells beauty art equipment and materials online.

1. No one shall advertise drugs equivalent to prescription drugs of defendants A for the sole purpose of violating the Pharmaceutical Affairs Act;

그럼에도 피고인은 2018. 8. 22.경 인터넷 F ‘G’에 ‘H’라는 닉네임으로 접속하여, ‘혁신적인 비만치료제 삭센다 도입’, ‘문의는언제나환영합니다^^’라는 내용의 글을 올려 전문의약품인 ‘삭센다’ 판매를 광고한 것을 비롯하여, 같은 해

8. On January 16, 2019, the advertisement on “the license”, which is a prescription medicine, was placed three times in total.

2. The Defendants may not sell or acquire medicine for sale unless the founders of the co-offenders who violate the Pharmaceutical Affairs Act.

Nevertheless, around August 2018, upon Defendant A’s contact with Defendant A to purchase “the license” as referred to in paragraph (1) above, the Defendants sent it to Defendant B, and Defendant B conspired to sell “the license” as a prescription drug by delivering goods supplied by zers to the said customer.

The Defendants received KRW 550,00 from I on January 16, 2019 following the above conspiracy, and then Defendant B delivered and sold “the” 1 boxes from J building K to I in Guro-gu Seoul Metropolitan Government, and Defendant B delivered and sold “the” 1 boxes from the fourth floor of the Orcheon-gu M building in Busan, on March 21, 2019.

As a result, the Defendants conspired to sell the prescription drugs at least twice, even though they are not a pharmacy founder.

3. Defendant B’s sole criminal conduct in violation of the Pharmaceutical Affairs Act is with the “N” in charge of sex surgery and administration, which was known to the general public around June 2018.

arrow